Fortaz and Death - a phase IV clinical study of FDA data

Summary:

Death is reported as a side effect among people who take Fortaz (ceftazidime), especially for people who are male, 60+ old, also take Tylenol, and have Chronic lymphocytic leukaemia.

The study is created by eHealthMe based on reports of 972 people who have side effects when taking Fortaz from the FDA, and is updated regularly.

What is Fortaz?

Fortaz has active ingredients of ceftazidime. eHealthMe is studying from 980 Fortaz users. Check the latest studies of Fortaz.

eHealthMe: drug outcomes in the real world

eHealthMe runs one of the largest post-marketing drug safety studies in the world. We study millions of patients and 5,000 more each day. Our data-driven phase IV clinical trials have been referenced on 800+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Tools to study our phase IV findings are available to the public, anonymous and free >>>.

On Aug, 01, 2026

972 people reported to have side effects when taking Fortaz.
Among them, 25 people (2.57%) died.

Among these 25 people:

What is the gender of people who died when taking Fortaz? *

female: 41.67 %
male: 58.33 %

What is the age of people who died when taking Fortaz? *

What are other drugs people take besides Fortaz? *

What are other side effects people have before they died? *

Weakness: 7 people, 28.00%
Acute Kidney Failure: 6 people, 24.00%
Dyspnea (difficult or laboured breathing): 6 people, 24.00%
Fatigue (feeling of tiredness): 5 people, 20.00%
Fever: 5 people, 20.00%
Pneumonia: 4 people, 16.00%
Dizziness: 4 people, 16.00%
Swallowing Difficulty: 4 people, 16.00%
Stress And Anxiety: 4 people, 16.00%
Multi-Organ Failure (multisystem organ failure): 4 people, 16.00%

What are the existing conditions these people have? *

Chronic Lymphocytic Leukaemia (cancer in which the bone marrow makes too many lymphocytes (a type of white blood cell)): 3 people, 12.00%
Malignant Lymphoid Neoplasm (malignant growth or tumour caused by abnormal and uncontrolled cell division in lymph node): 2 people, 8.00%
Cardiac Disorder: 2 people, 8.00%
Pain: 2 people, 8.00%
Nausea (feeling of having an urge to vomit): 2 people, 8.00%
Urinary Tract Infection: 1 person, 4.00%
Fungal Infection: 1 person, 4.00%
Insomnia (sleeplessness): 1 person, 4.00%
Hypogammaglobulinaemia (an abnormally low concentration of gamma globulin in the blood and increased risk of infection): 1 person, 4.00%
High Blood Cholesterol: 1 person, 4.00%

* Approximation only. Some reports may have incomplete information.

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Fortaz:

Fortaz (980 reports)

Expand to all the drugs that have ingredients of ceftazidime:

Death and drugs with ingredients of ceftazidime (286 reports)

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Fortaz:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Death:

Death (3,107 drugs)

Browse all the conditions that are associated with Death:

Death (3,686 conditions)

Related publications that referenced our studies

Chen F, Zhan Z, "Severe drug-induced immune haemolytic anaemia due to ceftazidime", Blood Transfusion, 2014 Jan .
Chen F, Zhan Z, "Severe drug-induced immune haemolytic anaemia due to ceftazidime", Blood Transfusion, 2014 Jan .

How the study uses the data?

The study uses data from the FDA. It is based on ceftazidime (the active ingredients of Fortaz) and Fortaz (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.